Massimiliano Presutti
Papers
1
Total Citations
6
H-Index
1
About
Massimiliano Presutti is a leading figure in urologic oncology, with a focused expertise in prostate cancer imaging and biomarker-driven patient selection. His research centers on the clinical translation of Prostate-Specific Membrane Antigen (PSMA), particularly its immunohistochemical expression in biopsy specimens and its correlation with PSMA-PET imaging outcomes. Presutti’s seminal 2024 work, which has already garnered 6 citations, provides critical insights into how PSMA expression at biopsy can refine patient selection for PSMA-PET, a key tool for staging high-risk disease. By bridging histopathology and molecular imaging, he addresses a fundamental challenge: why some patients with aggressive prostate cancer show false-negative PET results. His contributions help define the biological determinants of imaging success, directly impacting clinical decision-making for staging and restaging. Presutti’s work is notable for its translational rigor, offering a pathway to more personalized, image-guided management of prostate cancer. For students and researchers, his research exemplifies how integrating tissue biomarkers with advanced imaging can optimize precision oncology.
Research Focus
Key Achievements
Top Papers
- 1